What is the appropriate treatment for orthostatic hypotension?

Treatment of Orthostatic Hypotension

Begin with non-pharmacological interventions as first-line therapy, then add midodrine or droxidopa if symptoms persist, while carefully monitoring for supine hypertension. 1

Stepwise Treatment Algorithm

Step 1: Identify and Remove Causative Factors

• Review and discontinue medications that worsen orthostatic hypotension: diuretics, vasodilators, tricyclic antidepressants, phenothiazines, and α-adrenoreceptor antagonists 2, 3
• Correct volume depletion and treat underlying causes 2

Step 2: Non-Pharmacological Interventions (First-Line)

Immediate symptom relief:

• Acute water ingestion (≥480 mL) provides temporary relief within 30 minutes—recommended for occasional use in neurogenic orthostatic hypotension 1
• Avoid glucose or salt in the water as these reduce the pressor effect 1

Physical maneuvers:

• Leg crossing, squatting, and lower body muscle tensing increase blood pressure immediately—squatting provides the largest effect 1
• These require adequate prodrome and physical ability to perform safely 1

Compression garments:

• Must be at least thigh-high and preferably include the abdomen—shorter garments are ineffective 1
• Reduce venous pooling and improve orthostatic symptoms 4

Lifestyle modifications:

• Increase salt intake to 6-9 g (100-150 mmol; 1-2 teaspoons) daily and fluid intake to 2-3 L daily 4
• Sleep with head of bed elevated 10 degrees to prevent nocturnal polyuria and reduce supine hypertension 2, 4
• Eat frequent small meals to minimize postprandial hypotension 2, 3
• Avoid rapid postural changes and activities that increase intra-abdominal pressure 3

Step 3: Pharmacological Treatment (When Non-Pharmacological Measures Fail)

First-line medications:

Midodrine (5-20 mg three times daily):

• FDA-approved and supported by Level A evidence 2
• Take first dose before arising; avoid several hours before bedtime to prevent supine hypertension 2
• Dose-dependent increase in standing blood pressure 1
• Side effects: scalp tingling, piloerection, urinary retention, supine hypertension 1

Droxidopa (titrated dose):

• FDA-approved for neurogenic orthostatic hypotension 1, 3, 5
• Effective in Parkinson disease, pure autonomic failure, and multiple system atrophy 1
• May reduce falls 1
• Caution: Carbidopa decreases droxidopa effectiveness in Parkinson patients 1
• Side effects: supine hypertension, headache, dizziness, nausea 1

Second-line medication:

Fludrocortisone (0.05-0.3 mg daily):

• Start at 0.05-0.1 mg daily, titrate to 0.1-0.3 mg daily 2
• Increases plasma volume through sodium retention 1, 4
• Use only when supine hypertension is absent—other medications should be tried first if supine hypertension exists 1
• Side effects: edema, hypokalemia, headache; serious effects (adrenal suppression, immunosuppression) with doses >0.3 mg daily 1

Alternative agents for refractory cases:

• Pyridostigmine for patients refractory to other treatments 6
• Octreotide for postprandial or refractory neurogenic orthostatic hypotension 6
• Erythropoietin in diabetic patients with hemoglobin <11 g/dL (25-75 U/kg three times weekly, target hemoglobin 12 g/dL) 2
• Desmopressin acetate for nocturnal polyuria and morning orthostatic hypotension 2

Critical Management Considerations

The treatment goal is symptom relief and fall prevention, NOT blood pressure normalization 2, 7. Balance the need to increase standing blood pressure against the risk of supine hypertension 2.

Common pitfall: Supine hypertension frequently coexists with orthostatic hypotension, particularly in neurogenic forms 1, 8, 9. This complicates medication selection and requires:

• Avoiding fludrocortisone when supine hypertension is present 1
• Taking midodrine only during waking hours 2
• Head-up tilt sleeping to manage nocturnal hypertension 4

Neurogenic vs. non-neurogenic distinction matters: Neurogenic orthostatic hypotension (from neurodegenerative disorders, diabetes, autonomic neuropathies) requires more aggressive pharmacological intervention 1, 9. Non-neurogenic forms (medication-induced, dehydration) often respond to removing the cause and volume expansion 1.

Medication combinations: Use midodrine OR fludrocortisone first; combine both only in non-responders to monotherapy 2. The 2017 ACC/AHA/HRS guidelines provide the most comprehensive and recent framework for this stepwise approach 1.